Hims & Hers bought a skincare startup for $190 million 4 years ago. Today it shut it down.
Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public telehealth company.
SFGate13d
Bay Area startup, a few years after being bought for $131M, shuts down
Apostrophe had retained its own website and brand under Hims & Hers leadership, offering topical and oral medications for ...
Hims & Hers to shut down dermatology business Apostrophe
Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on ...
Opinion
Hims & Hers Stock Is Due for a Crash Diet. The Weight-Loss Drug Surge Is Fading Fast.
The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm that ...
Hims & Hers’ Weight-Loss Empire Hits a Gut-Wrenching End
Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...
Fierce Healthcare11d
Hims & Hers shutters Apostrophe in favor of its own tele-dermatology offerings
Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operation | Hims & Hers ...
Yahoo Finance4d
Hims & Hers stock tumbles as the FDA issues a warning about 'unapproved' weight loss drugs
Hims & Hers (HIMS), the millennial-skewed telehealth ... updated a page on its website outlining its concerns with the use of what it calls “unapproved GLP-1 drugs.” GLP-1 drugs are a class ...
The Motley Fool on MSN11d
The FDA's good news for Hims & Hers
Last week, the news on Hims & Hers was all about how a Texas court ruling confirmed ... But yesterday, the FDA clarified its ...
The Motley Fool6d
Why Hims & Hers Stock Popped on Monday
Hims & Hers app downloads surged 47% in February. Demand for GLP-1 weight-loss drugs is the most likely reason for the growth. But sales of such weight loss drugs are going away soon, and the ...
Seeking Alpha15d
Hims & Hers: The Odds Are In Your Favor, Here's How To Take Advantage (Rating Upgrade)
Hims & Hers Health is now reasonably valued after ... making it a one-stop website for digital healthcare. And its revenues primarily come from subscriptions -- 90%+ of its revenue is recurring ...
Seeking Alpha29d
Hims & Hers: After A 205% Gain, Downgrading To A Hold, But Options Present An Opportunity
Hims & Hers Health's stock has surged 205% since my ... I calculated in my previous article (if you include "Investment in website and mobile application development and internal-use software ...
Business Insider15d
Hims & Hers bought a skincare startup for $190 million 4 years ago. Today it shut it down.
Hims & Hers is shutting down the dermatology business ... According to a message on Apostrophe's website, all subscriptions will be canceled as of Friday and customers will lose access to their ...